Eagle Pharmaceuticals Inc Net Asset Quality Index
Eagle Pharmaceuticals Inc net asset quality index. Eagle Pharmaceuticals Inc (EGRX) has a Net Asset Quality Index of 62.3% as of June 2023. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $404.82 Million minus total liabilities of $152.78 Million yields net assets of $252.04 Million. A higher index indicates a stronger, lower-leverage balance sheet. See what is Eagle Pharmaceuticals Inc's book value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Eagle Pharmaceuticals Inc (2012–2022)
Net asset quality index of Eagle Pharmaceuticals Inc from 2012 to 2022. This chart shows how Eagle Pharmaceuticals Inc's Net Asset Quality Index has evolved across 11 annual periods from 2012 to 2022. As of June 2023, the index stands at 62.3%, representing net assets of $252.04 Million against total assets of $404.82 Million USD. Check EGRX strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Eagle Pharmaceuticals Inc Net Asset Quality Index by Year (2012–2022)
Eagle Pharmaceuticals Inc net asset quality index by year from 2012 to 2022. The table below presents the year-by-year Net Asset Quality Index for Eagle Pharmaceuticals Inc from 2012 to 2022, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see how much is Eagle Pharmaceuticals Inc worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2022 | 57.5% | $233.56 Million | $406.16 Million | $172.60 Million | ▼ -12.0 pp |
| 2021 | 69.5% | $176.45 Million | $253.73 Million | $77.28 Million | ▼ -3.9 pp |
| 2020 | 73.5% | $186.01 Million | $253.19 Million | $67.18 Million | ▲ +3.1 pp |
| 2019 | 70.4% | $179.17 Million | $254.55 Million | $75.38 Million | ▲ +3.0 pp |
| 2018 | 67.4% | $160.76 Million | $238.60 Million | $77.84 Million | ▲ +1.0 pp |
| 2017 | 66.3% | $179.14 Million | $270.06 Million | $90.92 Million | ▼ -4.5 pp |
| 2016 | 70.8% | $151.23 Million | $213.57 Million | $62.34 Million | ▼ -1.7 pp |
| 2015 | 72.5% | $90.34 Million | $124.61 Million | $34.26 Million | ▲ +10.5 pp |
| 2014 | 62.0% | $33.10 Million | $53.41 Million | $20.32 Million | ▲ +50.6 pp |
| 2013 | 11.3% | $2.05 Million | $18.10 Million | $16.05 Million | ▲ +139.5 pp |
| 2012 | -128.2% | $-12.10 Million | $9.44 Million | $21.54 Million | — |